Last September, results from a JDRF-funded study were announced by Sansum Diabetes Research Institute and JDRF. This study addresses one of the key limitations of early artificial pancreas systems – the challenge of mealtime dosing of insulin. This is because insulin delivered through the skin by a pump or injections works much slower than insulin […]
In 1921, a team of Canadian researchers including Frederick G. Banting, M.D., Charles H. Best, J.J.R. Macleod, Ph.D., and James B. Collip, Ph.D., isolated a newly discovered hormone they named “insulin” from calf pancreases (pancreata). They injected it into a teenage boy who had type 1 diabetes (T1D). The young man, Leonard Thompson, was confined […]
In December 2012, a study published in The Journal of the American Medical Association reported that people with type 1 diabetes (T1D) or who are at increased risk of developing the disease have smaller pancreases than people not at risk. Researchers studied pancreases from three groups of deceased donors: individuals with T1D, those with autoantibodies […]
By Ovidio Bermudez, M.D., and Jennifer Sommer, M.S., R.D. For our readers: Our goal is to help increase awareness of the dual diagnosis of an eating disorder and type 1 diabetes (T1D), which is referred to as “ED-DMT1.” To accomplish this, we asked two experts, a physician and a registered dietitian who treat ED-DMT1, to […]
By Kerri Sparling “Hi! I’m Kerri, and I have type 1 diabetes.” This is not normally the way I introduce myself to people. (Actually, this is never the way I introduce myself to people—bit of a creepy opener, wouldn’t it be?) I’m not shy when it comes to talking about my type 1 diabetes (T1D) […]
By Talley Henning Brown Whatever shape your travels take, it’s a good idea to pay extra respect to type 1 diabetes (T1D). JDRF’s own “road warrior,” Andy Bell, who was diagnosed with T1D at age 14, is certainly a case in point. “For me, the journey has always been more meaningful than the destination,” […]
A simple insulin-infusion warming device, called the InsuPatch, accelerates insulin delivery into the bloodstream by as much as 35 minutes. Speeding up the delivery and action of insulin and reducing the amount of time patients spend in a hyperglycemic state potentially reduces the risk of complications that result from the disease.
By Catherine Marschilok, M.S.N., C.D.E., Board Certified in Advanced Diabetes Management Children with diabetes are using pump therapy in greater numbers than ever before. When students with diabetes make the leap from injection therapy to insulin pump therapy, everyone involved in their care–including school nurses and health staff members–must be prepared to make the leap […]
By Catherine Marschilok, M.S.N., C.D.E., Board Certified in Advanced Diabetes Management We all know a diagnosis of type 1 diabetes (T1D) is hard on families as they learn to cope with a number of changes in their daily life. While people care, it is all too common for them to ask questions that reflect a […]
An insulin that needs to be injected only once per day and that reacts to blood sugar only when needed could mark a significant improvement in treating diabetes, requiring fewer injections and less glucose monitoring while reducing hypoglycemia.